Genetic/familial high-risk assessment: Colorectal version 1.2016: Clinical practice guidelines in oncology

Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Travis Bray, Jamie A. Cannon, Gregory Cooper, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. LynchRobert J. Mayer, Reid M. Ness, Scott E. Regenbogen, Niloy Jewel Samadder, Moshe Shike, Gideon Steinbach, David Weinberg, Mary Dwyer, Susan Darlow

Research output: Contribution to journalArticlepeer-review

Abstract

This is a focused update highlighting the most current NCCN Guidelines for diagnosis and management of Lynch syndrome. Lynch syndrome is the most common cause of hereditary colorectal cancer, usually resulting from a germline mutation in 1 of 4 DNA mismatch repair genes (MLH1, MSH2, MSH6, or PMS2), or deletions in the EPCAM promoter. Patients with Lynch syndrome are at an increased lifetime risk, compared with the general population, for colorectal cancer, endometrial cancer, and other cancers, including of the stomach and ovary. As of 2016, the panel recommends screening all patients with colorectal cancer for Lynch syndrome and provides recommendations for surveillance for early detection and prevention of Lynch syndrome-associated cancers.

Original languageEnglish (US)
Pages (from-to)1010-1030
Number of pages21
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2016

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Genetic/familial high-risk assessment: Colorectal version 1.2016: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this